BioNTech RNA Pharmaceuticals — ERA-LEARN

Skip to content
Skip to footer

Service Navigation

Home
About
Contact
newsalert
Twitter

Main Menu Search

Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Home
Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

SuppRESsion of immunopathology by nanOparticle deLiVEry of mRNA to monocytes

Home
Explore Partnerships
Partnerships
EuroNanoMed III
Joint Transnational Call for Proposals (2017) for “European Innovative Research & Technological Development Projects in Nanomedicine”
SuppRESsion of immunopathology by nanOparticle deLiVEry of mRNA to monocytes
BioNTech RNA Pharmaceuticals

Full name	BioNTech RNA Pharmaceuticals
Short name
Type of organisation	Large enterprise
Partner Role	Partner
Country	Germany

Back to project overview

Funded by the European Union under the Grant Agreement no. 101102316. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Commission. Neither the European Union nor the granting authority can be held responsible for them.

Sitemap
Imprint
Privacy Policy
Submit accessibility issues
Accessibility Statement

Follow us on Twitter
@ERALEARN_EU

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.